Hans Bishop - Agilent Technologies Independent Director

A -- USA Stock  

Buyout Trend

  Director
Mr. Hans Edgar Bishop serves as Independent Director of the Company. Mr. Bishop served as president, chief executive officer and a member of the Board of Directors of Juno Therapeutics, Inc. from September 2013 to March 2018 when Juno was acquired by Celgene Corporationrationration. From February 2012 until October 2012, Mr. Bishop was the chief operating officer of Photothera Inc., a latestage medical device company owned by Warburg Pincus, and he continued working with Warburg Pincus as an Executive in Residence until October 2013. Prior to joining Photothera Inc., Mr. Bishop served as executive vice president and chief operating officer at Dendreon Corporationrationration, a publiclytraded biopharmaceutical company, from January 2010 to September 2011
Age: 53  Director Since 2017      
408-345-8886  http://www.agilent.com
Bishop has also served as the president of the specialty medicine business at Bayer Healthcare Pharmaceuticals Inc. from December 2006 to January 2010, where he was responsible for a diverse portfolio of neurology, oncology and hematology products.

Management Efficiency

The company has accumulated 1.8 B in total debt with debt to equity ratio (D/E) of 37.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 2.09 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Yalon FarhiDarioHealth Corp
2016
Peter NeupertLaboratory Corporation Of Ameri
2013
Katherine NapierExact Sciences Corporation
2009
Aaref HilalyGuardant Health
2015
Jennifer WengGlobal Cord Blood Corporation
N/A
Robin SmithEMMAUS LIFE SCIENCES INC NEW
2019
Sally CrawfordExact Sciences Corporation
2008
Daniel LevangieExact Sciences Corporation
2010
Richard CollinsDexCom
2017
Robert MittelstaedtLaboratory Corporation Of Ameri
2009
Malcolm HoenleinDarioHealth Corp
2011
Maneesh AroraExact Sciences Corporation
2013
Bahija JallalGuardant Health
2019
Ian ZwickerEMMAUS LIFE SCIENCES INC NEW
2019
Dipchand NisharGuardant Health
2018
Allen KamerDarioHealth Corp
2017
Patrick JonesFluidigm Corporation
2011
Evan JonesFluidigm Corporation
2011
Eric TopolDexCom
2009
Garheng KongLaboratory Corporation Of Ameri
2013
Carlos PayaFluidigm Corporation
2017

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 16300 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Boulevard and employs 16,300 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President, Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President, Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Chairman of the Board
Robert Herbold, Independent Director

Stock Performance Indicators

Current Sentiment - A

Agilent Technologies Investor Sentiment

Most of Macroaxis users are presently bullish on Agilent Technologies. What is your sentiment towards investing in Agilent Technologies? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Search macroaxis.com